Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests

Why is the Fed governor calling for a rate cut? How will EU's new Russia oil price cap affect markets? What caused Amazon Web Services latest job cuts? Why is Congress cutting $9 billion in spending? How did Netflix's earnings impact its stock today? What are the implications of Trump's crypto 401(k) plan? Why did Jaguar Land Rover announce management layoffs?

Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests

benzinga.com/markets/equities/25/07/46485628/telomir-pharma-skyrockets-nearly-139-after-hours-as-cancer-drug-shows-breakthrough-results-beats

Telomir Pharmaceuticals Inc (NASDAQ:TELO) experienced an increase of 138.84% in its stock value during after-hours trading on Thursday, noting a regular trading session surge of 5.22% to reach $1.21.
What Happened: The surge in stock value followed the announcement of promising data…

This story appeared on benzinga.com, 2025-07-18 05:54:25.